The Connecticut Mental Health Center, Yale University School of Medicine, Department of Psychiatry, 34 Park Street, New Haven, CT 06519, USA.
Psychoneuroendocrinology. 2013 Sep;38(9):1532-44. doi: 10.1016/j.psyneuen.2012.12.022. Epub 2013 Jan 29.
Exogenous progesterone has been shown to attenuate the rewarding effects of cocaine. However, its effects on provoked drug craving, stress arousal and cognitive performance has not been systematically investigated in cocaine dependent men and women. Thus, we conducted a double-blind placebo-controlled study assessing the efficacy of progesterone in reducing provoked drug craving, stress system arousal and improving cognitive performance in cocaine dependent men and women.
Forty-two early abstinent treatment-seeking cocaine dependent individuals were randomly assigned to either daily doses of placebo (12M/9F) or micronized progesterone (12M/9F) (400 mg/day), for 7 days. Under experimental conditions, all subjects were exposed to three 5-min personalized guided imagery conditions (stress, cocaine cue, relaxing), one per day, consecutively in a random, counterbalanced order. Subjective craving, mood, hypothalamic-pituitary-adrenal (HPA) and cardiovascular output, and a cognitive measure of inhibitory control (Stroop Color Word Task) were assessed pre- and post imagery.
Progesterone relative to placebo significantly decreased cue-induced craving and cortisol responses and increased cue-induced ACTH. In addition, women but not men receiving progesterone reported lower ratings of negative emotion and higher ratings of relaxed mood following stress exposure. Improved Stroop performance was observed in all participants receiving progesterone, across all conditions.
Progesterone was selectively effective in reducing cocaine cue-induced but not stress-related cocaine craving as well as specific measures of the provoked arousal state. Findings suggest that progesterone's effects on drug craving and arousal are moderated by both the type of environmental cue exposure and gender.
已证实外源性孕酮可减弱可卡因的奖赏效应。然而,其对诱发的药物渴求、应激唤醒和认知表现的影响尚未在可卡因依赖的男性和女性中进行系统研究。因此,我们进行了一项双盲安慰剂对照研究,评估孕酮对减少可卡因依赖的男性和女性诱发的药物渴求、应激系统唤醒和改善认知表现的疗效。
42 名早期戒断的寻求治疗的可卡因依赖者被随机分配至每日接受安慰剂(12 名男性/9 名女性)或微粉化孕酮(12 名男性/9 名女性)(400mg/天)治疗,为期 7 天。在实验条件下,所有受试者每天依次接受三个 5 分钟的个性化引导想象条件(应激、可卡因线索、放松),随机、平衡顺序进行。在想象之前和之后评估主观渴求、情绪、下丘脑-垂体-肾上腺(HPA)和心血管输出以及抑制控制的认知测量(Stroop 颜色-单词任务)。
与安慰剂相比,孕酮显著降低了线索诱导的渴求和皮质醇反应,并增加了线索诱导的促肾上腺皮质激素。此外,接受孕酮治疗的女性而非男性在应激暴露后报告负面情绪评分较低,放松情绪评分较高。所有接受孕酮治疗的参与者在接受孕酮治疗的所有条件下,Stroop 表现均得到改善。
孕酮选择性地有效减少了可卡因线索诱导的而非与应激相关的可卡因渴求,以及诱发的唤醒状态的特定测量。研究结果表明,孕酮对药物渴求和唤醒的影响受到环境线索暴露类型和性别两者的调节。